These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 6247313)
1. Enterobacter cloacae outer membrane permeability to ceftizoxime (FK 749) and five other new cephalosporin derivatives. Kojo H; Shigi Y; Nishida M J Antibiot (Tokyo); 1980 Mar; 33(3):317-21. PubMed ID: 6247313 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory and bactericidal activity of cefmetazole and seven other beta-lactams against different bacterial inocula. Esposito S; Galante D; Barba D Chemioterapia; 1986 Apr; 5(2):101-4. PubMed ID: 3518963 [TBL] [Abstract][Full Text] [Related]
3. Detection of resistance due to inducible beta-lactamase in Enterobacter aerogenes and Enterobacter cloacae. Huber TW; Thomas JS J Clin Microbiol; 1994 Oct; 32(10):2481-6. PubMed ID: 7814486 [TBL] [Abstract][Full Text] [Related]
4. Antibacterial activity of ceftizoxime, a beta-lactamase-stable cephalosporin. Fu KP; Neu HC Antimicrob Agents Chemother; 1980 Apr; 17(4):583-90. PubMed ID: 6967294 [TBL] [Abstract][Full Text] [Related]
5. Antibacterial activity of ceftizoxime (FK 749), a new cephalosporin, against cephalosporin-resistant bacteria, and its stability to beta-lactamase. Kojo H; Nishida M; Goto S; Kuwahara S Antimicrob Agents Chemother; 1979 Nov; 16(5):549-53. PubMed ID: 316684 [TBL] [Abstract][Full Text] [Related]
6. Comparative antibacterial activities of 7 alpha-methoxy cephalosporins and 7 beta-methoxyiminoacetamido cephalosporins against Bacteroides fragilis. Kesado T; Watanabe K; Asahi Y; Isono M; Ueno K Antimicrob Agents Chemother; 1984 Jan; 25(1):131-3. PubMed ID: 6322676 [TBL] [Abstract][Full Text] [Related]
7. Ceftizoxime (FK 749), a new parenteral cephalosporin: in vitro and in vivo antibacterial activities. Kamimura T; Matsumoto Y; Okada N; Mine Y; Nishida M; Goto S; Kuwahara S Antimicrob Agents Chemother; 1979 Nov; 16(5):540-8. PubMed ID: 525994 [TBL] [Abstract][Full Text] [Related]
8. Antibacterial activity of HR-756, cefoxitin and cefuroxine against multiply antibiotic-resistant strains of Enterobacteriaceae and Pseudomonas aeruginosa. Legakis NJ; Kafetzis DA; Papadatos CJ; Papavassiliou JT Chemotherapy; 1980; 26(5):334-43. PubMed ID: 6248301 [TBL] [Abstract][Full Text] [Related]
9. Effect of beta-lactamase induction on susceptibility to cephalosporins in Enterobacter cloacae and Serratia marcescens. Okonogi K; Sugiura A; Kuno M; Higashide E; Kondo M; Imada A J Antimicrob Chemother; 1985 Jul; 16(1):31-42. PubMed ID: 3900023 [TBL] [Abstract][Full Text] [Related]
10. Cefpirome (HR 810): lack of selection of beta-lactamase overproducing variants. Cullmann W; Dick W J Antibiot (Tokyo); 1985 Jul; 38(7):912-9. PubMed ID: 3875601 [TBL] [Abstract][Full Text] [Related]
11. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics]. Miwatani T; Takeda Y; Kotera K; Nishimura T; Takashima T; Hiromatsu K; Tabuki K; Fujimoto S; Kamiki T; Yoshizaki E; Yabuuchi E; Shimizu Y; Matsunaga K; Yamanaka K; Furuta I; Iimori M; Kodama J; Tanaka M; Maejima K; Nukina M; Takashima E; Takahashi M; Harikane O; Masutani T Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368 [TBL] [Abstract][Full Text] [Related]
12. Antibacteroides and beta-lactamase inhibitory activities of moxalactam. Fu KP; Neu HC J Antimicrob Chemother; 1981 Oct; 8(4):337-41. PubMed ID: 6271727 [No Abstract] [Full Text] [Related]
13. The activity and beta-lactamase stability of cefotetan compared to other beta-lactam antibiotics. Neu HC; Chin NX Chemioterapia; 1985 Aug; 4(4):271-7. PubMed ID: 3876887 [TBL] [Abstract][Full Text] [Related]
14. [Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins]. Baumgärtner M; Dickgiesser N; Müller S; Wundt W Arzneimittelforschung; 1981; 31(10):1677-81. PubMed ID: 6274361 [TBL] [Abstract][Full Text] [Related]
15. The effect of beta-lactamase stability, penetration, and target affinity on the activity of cefazolin, cefamandole, cefoxitin, and cefuroxime. Harper PB Clin Ther; 1984; 6(3):310-24. PubMed ID: 6609771 [TBL] [Abstract][Full Text] [Related]
16. [In vitro antibacterial activity of cefodizime (HR 221) on 323 hospital strains of Gram negative bacilli. Comparison with cefotiam, cefoperazone, cefotetan and cefotaxime]. Le Noc P; Bryskier A; Le Noc D Pathol Biol (Paris); 1985 May; 33(5):399-403. PubMed ID: 3897972 [TBL] [Abstract][Full Text] [Related]
17. The in vitro antibacterial activity of cefotaxime compared with that of cefuroxime and cefoxitin. King A; Warren C; Shannon K; Phillips I J Antimicrob Chemother; 1980 Jul; 6(4):479-94. PubMed ID: 6253433 [No Abstract] [Full Text] [Related]
18. The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics. Neu HC Annu Rev Pharmacol Toxicol; 1982; 22():599-642. PubMed ID: 6282190 [No Abstract] [Full Text] [Related]
19. Pharmacokinetics of the new cephalosporins. Brogard JM; Comte F Antibiot Chemother (1971); 1982; 31():145-210. PubMed ID: 6277241 [No Abstract] [Full Text] [Related]
20. Comparative beta-lactamase hydrolysis of and inhibition by 7-aminothiazolyl alpha-methoxyimino cephalosporins. Jones RN; Wilson HW Infection; 1982; 10(5):303-6. PubMed ID: 6293977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]